To understand the mechanistic relationship between SOS2 and the therapeutic effects of sulfarotene in association with the tumorigenic properties of HCC TRCs, we first found that the protein levels of SOS2 in TRCs were significantly higher than in their parental HCC cells and normal liver cells (Fig. 4a). Here, SOS2 is linked to hepatocellular carcinoma.